116 related articles for article (PubMed ID: 7000079)
1. Skeletal metabolism in Paget's disease of bone.
Krane SM
Arthritis Rheum; 1980 Oct; 23(10):1087-94. PubMed ID: 7000079
[TBL] [Abstract][Full Text] [Related]
2. Metabolic consequences of bone turnover in Paget's disease of bone.
Krane SM; Simon LS
Clin Orthop Relat Res; 1987 Apr; (217):26-36. PubMed ID: 3549093
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover in Paget's disease.
Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
[TBL] [Abstract][Full Text] [Related]
5. Paget's disease of bone.
Krane SM
Clin Orthop Relat Res; 1977; (127):24-36. PubMed ID: 410574
[No Abstract] [Full Text] [Related]
6. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
Kelleher PC
Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
[TBL] [Abstract][Full Text] [Related]
8. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
9. The origin of urinary hydroxylysyl glycosides in Paget's disease of bone and in primary hyperparathyroidism.
Askenasi R; De Backer M; Devos A
Calcif Tissue Res; 1976 Nov; 22(1):35-40. PubMed ID: 1000341
[TBL] [Abstract][Full Text] [Related]
10. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
[TBL] [Abstract][Full Text] [Related]
11. [Disorder of bone quality in Paget's disease].
Tsurukami H
Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover in Paget's disease: biochemical and kinetic measurements during salmon calcitonin therapy.
Hosking DJ; Vennart W; Huddlestone LB
Calcif Tissue Int; 1981; 33(5):471-6. PubMed ID: 6797699
[TBL] [Abstract][Full Text] [Related]
13. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
[TBL] [Abstract][Full Text] [Related]
14. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
Shai F; Baker RK; Wallach S
J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
Bower L; Manley G
J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
[TBL] [Abstract][Full Text] [Related]
16. Galactosyl hydroxylysine in assessment of Paget's bone disease.
Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
[TBL] [Abstract][Full Text] [Related]
17. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
[TBL] [Abstract][Full Text] [Related]
18. In vitro synthesis of normal bone (Type I) collagen by bones of Paget's disease patients.
Cheung HS; Singer FR; Mills B; Nimni ME
Proc Soc Exp Biol Med; 1980 Apr; 163(4):547-52. PubMed ID: 7384078
[No Abstract] [Full Text] [Related]
19. [Biological exploration of Paget's disease (author's transl)].
Nagant de Deuxchaisnes C; Rombouts-Lindemans C
J Belge Rhumatol Med Phys; 1974; 29(5-6):243-92. PubMed ID: 4470109
[No Abstract] [Full Text] [Related]
20. Long-term treatment of Paget's disease of bone with salmon calcitonin.
Sturtridge WC; Harrison JE; Wilson DR
Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
